HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design
Women living with HIV experience a disproportionate burden of persistent high-risk human papillomavirus infection and cervical cancer, yet they remain underrepresented in pivotal immunotherapy trials. Consequently, the effects of HIV-associated immune …